Document Detail


The sensitization of glioma cells to cisplatin and tamoxifen by the use of catechin.
MedLine Citation:
PMID:  18581255     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Telomerase expression strongly correlates with the grade of malignancy in glioma with inhibition illustrating a definite increase in chemosensitivity. This study was designed to investigate the effects of a green tea derivative, epigallocatechin-3-gallate (EGCG); together with either cisplatin or tamoxifen in glioma, and to investigate whether these effects are mediated through telomerase suppression. EGCG showed a significant cytotoxic effect on 1321N1 cells after 24 h and on U87-MG cells after 72 h (P < 0.001) without significantly affecting the normal astrocytes. Treatment with EGCG inhibited telomerase expression significantly (P < 0.01) and enhanced the effect of cisplatin and tamoxifen in both 1321N1 (P < 0.01) and U87-MG (P < 0.001) cells. EGCG, as a natural product has enormous potential to be an anti-cancer agent capable of enhancing tumour cell sensitivity to therapy.
Authors:
Amal Shervington; Vidya Pawar; Sharad Menon; Dipti Thakkar; Rahima Patel
Related Documents :
19014415 - Both telomeric and non-telomeric dna damage are determinants of mammalian cellular sene...
16600555 - Senescent fibroblasts induce moderate stress in lung epithelial cells in vitro.
10948255 - Aintegumenta promotes petal identity and acts as a negative regulator of agamous.
15034305 - The frequency of homologous recombination in human alt cells.
20197285 - Impact of drought on the temporal dynamics of wood formation in pinus sylvestris.
7763005 - C-ha-ras oncogene transfection does not affect nk cell sensitivity of human colorectal ...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't     Date:  2008-06-26
Journal Detail:
Title:  Molecular biology reports     Volume:  36     ISSN:  1573-4978     ISO Abbreviation:  Mol. Biol. Rep.     Publication Date:  2009 May 
Date Detail:
Created Date:  2009-04-02     Completed Date:  2009-07-23     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  0403234     Medline TA:  Mol Biol Rep     Country:  Netherlands    
Other Details:
Languages:  eng     Pagination:  1181-6     Citation Subset:  IM    
Affiliation:
Brain Tumour North West, Faculty of Science, University of Central Lancashire, Preston, UK. aashervington@uclan.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Antineoplastic Agents / pharmacology*
Catechin / analogs & derivatives,  pharmacology*
Cell Death / drug effects
Cell Line, Tumor
Cell Survival / drug effects
Cisplatin / pharmacology*
Drug Screening Assays, Antitumor
Gene Expression Regulation, Neoplastic / drug effects
Glioma / pathology*
Humans
Tamoxifen / pharmacology*
Telomerase / genetics,  metabolism
Chemical
Reg. No./Substance:
0/Antineoplastic Agents; 10540-29-1/Tamoxifen; 154-23-4/Catechin; 15663-27-1/Cisplatin; 989-51-5/epigallocatechin gallate; EC 2.7.7.49/Telomerase

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Magnetic resonance evaluation of liver and myocardial iron deposition in thalassemia intermedia and ...
Next Document:  Investigation of Lpin1 as a candidate gene for fat deposition in pigs.